Accuray Industry-Expert Theater
Sunday, October 1st from 2:00 to 3:00pm – Theater 1
Join us at our symposium hosted at ASTRO for two invigorating debates that delve into the forefront of prostate cancer therapies. Prepare to engage as we navigate through contrasting perspectives on topics that are reshaping the trajectory of modern prostate cancer treatment with SBRT and ADT. This event promises to be a platform for lively exchange, allowing radiation oncologists, physicists, radiation therapists, and nurses to broaden their perspectives. Share in compelling discussions as Radiation Oncologist thought leaders debate differing viewpoints on contemporary topics that highly impact prostate cancer care.
Expert Encounters: A Live Debate on the Merits and Controversies of SBRT and ADT in the Management of Prostate Cancer
Introduction:
Dr. Seth Blacksburg, Chief Medical Officer, Accuray
Debate #1
ADT is a Critical Component in the Management of UPCa in the Modern Era
Moderated By:
Dr. Jonathan A. Haas, Chairman, Perlmutter Cancer Center Radiation Oncology-Long Island, Clinical Professor of Radiation Oncology, NYU Long Island School of Medicine, Mineola
Dr. Amar Kishan
Associate Professor, Chief of Genitourinary Oncology Service, Vice Chair of Clinical and Translational Research, Department of Radiation Oncology
University of California, Los Angeles
VS
Dr. Mack Roach
Professor, Departments of Radiation Oncology & Urology
University of California, San Francisco
Dr. Amar Kishan
Associate Professor, Chief of Genitourinary Oncology Service, Vice Chair of Clinical and Translational Research, Department of Radiation Oncology
University of California, Los Angeles
VS
Dr. Mack Roach
Professor, Departments of Radiation Oncology & Urology
University of California, San Francisco
Debate #2
Prostate SBRT has emerged as the ablative therapy of choice for the majority of prostate cancer
Moderated By:
Dr. Seth Blacksburg, Chief Medical Officer, Accuray
Dr. Richard G. Stock
Professor of Radiation Oncology
Mount Sinai Health System, New York
VS
Dr. Robert Timmerman
Chair of the Department of Radiation Oncology
UT Southwestern Medical Center, Dallas
Dr. Richard G. Stock
Professor of Radiation Oncology
Mount Sinai Health System, New York
VS
Dr. Robert Timmerman
Chair of the Department of Radiation Oncology
UT Southwestern Medical Center, Dallas
Conclusion:
Dr. Seth Blacksburg, Chief Medical Officer, Accuray
Fill out the form below and an Accuray representative will reach out to you shortly.
